News
AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback